Forbes on the future

How will the new administration regulate weight-loss drugs? The truth is, we don't know yet. Forbes considers the question, though, in "Which Side Will Makary Take In The Fight Over Weight Loss Drugs?" with a bit of input from APC, of course.

Related posts

The Washington Post’s story “Eli Lilly ramps up its fight against imitation weight-loss drugs”...

One of the better articles we've seen lately comes from USA Today, explaining what is likely to...

Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...